The North American Artificial Organs and Bionics Market Size is valued at USD 7.33 billion in 2022 and is poised to reach USD 11.37 billion by 2027, showcasing a CAGR of 9.2% during the forecast period 2022 to 2027.
The rising prevalence of impairments and organ failures, technical advancements, and the high incidence of amputations due to traffic accidents contribute to the growth of the artificial organs and bionics market in North America. In addition, rising healthcare expenditures, rising income levels, a growing preference for bionics due to better and faster recovery than prosthetics, an increase in surgical procedures in place of medical tourism, and less competition than mature countries have stimulated market players' interest in emerging markets.
Growth in the number of transplants and the number of people waiting for donors drive the market for artificial organs and bionics. In 2020, the Human Resource and Services Administration (HRSA) estimated that there would be over 112,000 people on the national waiting list in the United States. According to the HRSA report, a person is added to the transplant waiting list every 10 minutes in the United States, increasing the demand for artificial medical devices. In addition, loss of blood, drug misuse, traumatic trauma, and other acute disorders are significant causes of organ failure.
Additionally, lifestyle diseases such as poor eating habits, smoking, excessive alcohol consumption, and a lack of exercise are vital causes of organ failure. Furthermore, advancements in healthcare facilities and the availability of improved artificial support systems are likely to enhance the demand for artificial organs and bionics.
Advances in the science of 3D bioprinting, which is used to manufacture artificial organs, have proven to be vital in organ transplantation. 3D bioprinting is in increasing demand since it reduces the risk of organ rejection. Furthermore, artificial intelligence is on the verge of reshaping artificial device trends.
Fear of device malfunction, risk of artificial organ compatibility, and their consequences, among other factors, may impact market growth. Some of the constraining aspects expected to hinder the market's growth include the high costs of organ transplantation procedures and the rising prices of medical bionic implants.
This research report on the North America Artificial Organs and Bionics Market has been segmented and sub-segmented into the following categories
By Product:
By Technology:
By Fixation Type:
By Country:
Geographically, the North American region leads the global artificial organs and bionics market due to an increase in injuries and organ failures in the North American area. In addition, rising income levels and increased healthcare spending are also contributing to the market's expansion.
The U.S artificial organs and bionics market has the most significant market share in the North American region. The dominance of the North American area in the artificial organs and bionics market is aided by the increased frequency of chronic diseases and the growing desire for non-invasive surgical treatments.
The Canadian artificial organs and bionics market is projected to be boosted by the availability of well-developed healthcare infrastructure & technological advancements such as electrical bionics and mechanical bionics.
KEY MARKET PLAYERS
Promising Companies dominating the North American Artificial Organs and Bionics Market Profiled in the Report are Jarvik Heart Inc, Asahi Kasei Medical Co., Ltd, Berlin Heart GmbH, Medtronic, Inc., Cochlear Ltd., Second Sight Medical Products, Inc., Ossur, Worldheart Corporation, Thoratec Corporation, Gambro AB, Lifenet Health, Boston Scientific Corporation, F Hoffman-La Roche Ltd, Orthofix International N.V., Biomet, Inc.,
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Artificial Organs
5.1.2.1 Artificial Heart
5.1.2.2 Artificial Kidney
5.1.2.3 Artificial liver
5.1.2.4 Artificial pancreas
5.1.2.5 Artificial lungs
5.1.3 Bionics
5.1.3.1 Vision bionics
5.1.3.2 Ear bionics
5.1.3.3 Orthopedic bionic
5.1.3.4 Cardiac Bionics
5.1.3.5 Brain bionics
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Technology
5.2.1 Introduction
5.2.2 Electronic bionics
5.2.3 Mechanical bionics
5.2.4 Y-o-Y Growth Analysis, By Technology
5.2.5 Market Attractiveness Analysis, By Technology
5.2.6 Market Share Analysis, By Technology
5.3 Type of fixation
5.3.1 Introduction
5.3.2 Implantable
5.3.3 Externally worn
5.3.4 Y-o-Y Growth Analysis, By Type of fixation
5.3.5 Market Attractiveness Analysis, By Type of fixation
5.3.6 Market Share Analysis, By Type of fixation
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technology
6.1.3.4 By Type of fixation
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technology
6.1.4.4 By Type of fixation
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technology
6.1.5.4 By Type of fixation
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Orthofix International N.V.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Biomet, Inc.
8.3 Medtronic, Inc.
8.4 Cochlear Ltd.
8.5 Second Sight Medical Products, Inc.
8.6 Ossur
8.7 Ekso Bionics
8.8 St. Jude Medical, Inc.
8.9 Baxter International, Inc.
8.10 Abiomed Inc.
8.11 Asahi Kasei Medical Co., Ltd
8.12 Berlin Heart GmbH
8.13 Boston Scientific Corporation
8.14 F Hoffman-La Roche Ltd
8.15 Worldheart Corporation
8.16 Thoratec Corporation
8.17 Gambro AB
8.18 Lifenet Health
8.19 Jarvik Heart Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
